IN RE Vs. CHIL TERN INTERNATIONAL PVT LTD

JUDGEMENT

(1.) A meeting of the Equity Shareholders of the Applicant company, be convened and to be held at 802, Allpha, Hiranadani Business Park, Powai, Mumbai 400 073, Maharashtra, on Wednesday, 24th May, 2017 at 10.00 a.m. for the purpose of considering and if thought fit, approving with or without modification(s) the proposed Scheme of Amalgamation of Chiltem International Private Limited ('the Transferor Company') with Chiltern Clinical Research India Private Limited ('the Transferee Company').

(2.) At least 30 clear days before the said meeting of the Equity Shareholders of the Applicant Company to be held as aforesaid, a notice convening the said meeting at the place, day, date and time aforesaid, together with a copy of the Scheme, a copy of the Explanatory Statement required to be sent under Section 230 of the Companies Act, 2013 and the prescribed Form of Proxy, shall be sent by the Registered Post or by Air-mail or by courier or by speed post or by hand delivery to each of the Equity Shareholders of the Applicant Company at their respective registered or last known address or by e-mail to the registered e-mail address of the Equity Shareholders as per the records of the Applicant Company.

(3.) At least 30 clear days before the meeting of the Equity Shareholders of the Applicant Company to be held as aforesaid, a notice convening the said meeting, at the place, date and time aforesaid and stating that copies of the Scheme of Amalgamation and the statement required to be furnished pursuant to Section 230 of the Companies Act, 2013 and that the Form of Proxy can be obtained free of charge at the Registered Office of the Applicant Company as aforesaid.